Stockscreener 앱 받기
26.53
2.03%
-0.63
전일 마감가:
$27.16
열려 있는:
$27.17
하루 거래량:
49,015
Relative Volume:
1.07
시가총액:
$1.16B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+10.60%
1개월 성능:
-25.44%
6개월 성능:
-44.19%
1년 성능:
+0.00%
1일 변동 폭
$26.02
$27.49
1주일 범위
$21.09
$28.00
52주 변동 폭
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
26.51 | 1.19B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
479.56 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
176.67 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.37 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
45.19 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
248.82 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World
GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World
Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Anbio Biotechnology Class A Shares Took Off - TipRanks
Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa
Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria
Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks
Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com
Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews
Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
S&P 500 Futures Up in Premarket Trading; QXO, Mosaic Lag - Barron's
Anbio Biotechnology falls -5.8% - MSN
Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - The Globe and Mail
Intel, Oracle among market cap stock movers on Monday - Investing.com
Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛
Anbio Biotechnology Reports Earnings Results for the Half Year Ended June 30, 2025 - marketscreener.com
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Coupang and Regencell among market cap stock movers on Friday By Investing.com - Investing.com India
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Year-End Review | The 2025 US IPO Gainers List is Out! Anbio Biotechnology Soars Over 570%, 'First Stablecoin Stock' Circle Surges More Than 180% - 富途牛牛
Anbio Biotechnology rises 11.2% - MSN
Why Anbio Biotechnology Class A Shares Are Rising - TipRanks
Top US Stock Losers Today (December 10, 2025): Why Polestar, AeroVironment, Aegon and Other Names Are Sinking - ts2.tech
Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets - TechStock²
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside - DirectorsTalk Interviews
Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga
Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
Anbio Biotechnology trading resumes - MSN
eToro adds 39 US stocks to lineup of investment instruments - FX News Group
Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView
Anbio Biotechnology rises 15.4% - MSN
Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks
Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent
Anbio Biotechnology Appoints New Auditor - TipRanks
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility In The Healthcare Sector - DirectorsTalk Interviews
[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
AMD, Palantir among market cap stock movers on Thursday By Investing.com - Investing.com Australia
Medtech test developer Anbio files for $9M US IPO - MSN
Anbio Biotechnology (NNNN) 재무 분석
Anbio Biotechnology (NNNN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
5.28%
자본화:
|
볼륨(24시간):